(26 days)
Not Found
No
The document describes a vital signs monitor with standard physiological measurements and a modification to interface with a different pulse oximeter. There is no mention of AI or ML in the intended use, device description, or performance studies.
No.
The device is a vital signs monitor that measures and displays physiological parameters; it does not directly treat or alleviate a disease or condition.
No
The device is a vital signs monitor that measures physiological parameters. It does not analyze these measurements to provide a diagnosis of a disease or condition.
No
The device description clearly states it is a "Vital Signs Monitor, Model 53000 Series" and describes hardware components like NIBP, Temperature, and SpO2 channels, as well as interfacing with pulse oximeters. While software is mentioned as being modified, the device itself is a physical monitor with integrated hardware.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze specimens from the human body. The device description clearly states that the VSM series monitors are used for noninvasive measurements of vital signs (blood pressure, pulse rate, temperature, and SpO2). These measurements are taken directly from the patient's body, not from a sample or specimen collected from the body.
- The intended use and device description focus on monitoring physiological parameters. The device measures and displays real-time vital signs, which are physiological indicators of a patient's health status. This is distinct from the purpose of an IVD, which is to provide information about a patient's health by analyzing a biological sample.
Therefore, the VSM series of monitors, as described, falls under the category of a non-invasive patient monitoring device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The VSM series of monitors is intended to be used by clinicians and medically qualified personnel for monitoring of noninvasive blood pressure, pulse rate, body temperature, noninvasive functional oxygen saturation of arteriolar hemoglobin (SpO2), and body temperature in normal and axillary modes of neonatal, pediatric and adult patients.
The most likely locations for patients to be monitored are general medical and surgical floors, general hospital and alternate care environments. This device is available for sale only upon the order of a physician or licensed health care professional. Demographic: Prescription Use
Product codes
MWI, DXN, DQA, FLL
Device Description
The VSM, Vital Signs Monitor, Model 53000 Series, (VSM 300) provides real time monitoring and display of noninvasive blood pressure (NIBP), pulse rate, body temperature and noninvasive oxygen saturation of arteriolar hemoglobin (SpO2).
- . NIBP - Noninvasive Blood Pressure is intended to noninvasively measure systolic, diastolic and mean arterial pressures (MAP).
- Temperature – Intermittent thermometer takes patient temperature in oral, axillary or rectal mode. .
- .. SpO2 - Pulse Oximetry channel is intended to noninyasively measure oxygen saturation of arteriolar hemoglobin at a peripheral measurement site.
The subject device is a modified version of the Model 53000 Series vital signs monitor, which was cleared for marketing under 510(k) K031740. The Model 53000 Series vital signs monitor has been modified to allow it to interface with the Masimo pulse oximeter as an alternative to the Nellcor MP506A pulse oximeter. The Masimo and Nellcor MP506A pulse oximeters are very similar in basic functionality and in their connection to the Model 53000 Series main board. The main board software has been modified to interpret the Masimo pulse oximeter protocol.
The modified Vital Signs Monitor, Model 53000 Series (VSM 300) monitor communicates to the user the same basic information as the Model 53000 Series vital signs monitor, specifically:
- . Saturation,
- Pulse rate,
- . Pleth waveform.
- . Trigger waveform for audible beep, and
- . Status information (e.g., sensor type, board integrity).
In addition, the user display of the above information (e.g., saturation, pulse rate, error codes) remains unchanged.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
neonatal, pediatric and adult patients
Intended User / Care Setting
The VSM series of monitors is intended to be used by clinicians and medically qualified personnel. The most likely locations for patients to be monitored are general medical and surgical floors, general hospital and alternate care environments.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The subject device has been tested in accordance with Welch Allyn documents 831-1031-02, "PE Test Report, VSM 300 Update" and 831-1050-00, "Test Report, VSM 3 Masimo" using production equivalent units prior to market release. A risk analysis identifying potential hazards and documenting mitigation of the hazards has been developed and applied as part of Welch Allyn Protocol's product development procedure. Welch Allyn Protocol's Quality System conforms to 21 CFR 820 and is certified to ISO 9001 and ISO 13485.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo for Welch Allyn. The logo is in a bold, sans-serif font. The letters are black, and the background is white. The logo is simple and easy to read.
3027
3. Premarket Notification [510(k)] Summary
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92. Information supporting claims of substantial equivalence, as defined under the Federal Food, Drug and Cosmetic Act, respecting safety and effectiveness, is outlined below.
| Date Prepared: | October 14, 2005 |
|---|---|
| Name of Submitter: | Welch Allyn Protocol, Inc. |
| 8500 S.W. Creekside Place | |
| Beaverton, OR 97008-7107 USA |
Contact:
John Sawyer, Vice President, Worldwide Regulatory Affairs
Phone: (315) 685-4571
Fax: (315) 685-2532 |
| Device Proprietary Name: | VSM, Vital Signs Monitor, Model 53000 Series ( VSM 300) |
| Classification Name: | The Vital Signs Monitor is classified under:
Monitor, Physiological, Patient, (without Arrhythmia Detection or
Alarms), 21 CFR 870.2300, Product Code MWI;
Noninvasive Blood Pressure Measurement System, 21 CFR
870.1130, Product Code DXN;
Oximeter, 21 CFR 870.2700, Product Code DQA; and
Thermometer, Electronic, Clinical, 21 CFR 880.2190, Product Code
FLL |
| Common/Usual Names: | Multi-parameter Physiological Patient Monitor,
Noninvasive Blood Pressure Measurement System,
Pulse Oximeter,
Electronic Thermometer |
| Predicate Device: | The predicate device is Welch Allyn Protocol, Inc.'s VSM Vital
Signs Monitor, Model 53000 Series, which was cleared for
marketing under 510(k) K031740. The subject device is the result
of a modification to the predicate, by incorporation of an optional
Masimo pulse oximeter. The intended use of the predicate device
has not changed as a result of this modification. |
| Device Description: | The VSM, Vital Signs Monitor, Model 53000 Series, (VSM 300)
provides real time monitoring and display of noninvasive blood |
| 510(k) Summary - Page 1 of 3 | |
1 - 1 - 1 - 1 - 1 - 1 -
1
WelchAllyn
Special 510(k) Premarket Notification Modification to Vital Signs Monitor
79 24 3
pressure (NIBP), pulse rate, body temperature and noninvasive oxygen saturation of arteriolar hemoglobin (SpO2).
- . NIBP - Noninvasive Blood Pressure is intended to noninvasively measure systolic, diastolic and mean arterial pressures (MAP).
- 트 Temperature – Intermittent thermometer takes patient temperature in oral, axillary or rectal mode. .
- .. SpO2 - Pulse Oximetry channel is intended to noninyasively measure oxygen saturation of arteriolar hemoglobin at a peripheral measurement site.
The subject device is a modified version of the Model 53000 Series vital signs monitor, which was cleared for marketing under 510(k) K031740. The Model 53000 Series vital signs monitor has been modified to allow it to interface with the Masimo pulse oximeter as an alternative to the Nellcor MP506A pulse oximeter. The Masimo and Nellcor MP506A pulse oximeters are very similar in basic functionality and in their connection to the Model 53000 Series main board. The main board software has been modified to interpret the Masimo pulse oximeter protocol.
The modified Vital Signs Monitor, Model 53000 Series (VSM 300) monitor communicates to the user the same basic information as the Model 53000 Series vital signs monitor, specifically:
- . Saturation,
- Pulse rate,
- . Pleth waveform.
- . Trigger waveform for audible beep, and
- . Status information (e.g., sensor type, board integrity).
In addition, the user display of the above information (e.g., saturation, pulse rate, error codes) remains unchanged.
Intended Use:
The VSM series of monitors is intended to be used by clinicians and medically qualified personnel for monitoring of noninvasive blood pressure, pulse rate, body temperature, noninvasive functional oxygen saturation of arteriolar hemoglobin (SpO2), and body temperature in normal and axillary modes of neonatal, pediatric and adult patients. The most likely locations for patients to be monitored are general medical and surgical floors, general hospital and alternate care environments. This device is available for sale only upon the order of a physician or licensed health care professional.
2
Image /page/2/Picture/4 description: The image shows the logo for Welch Allyn. The text is in a bold, sans-serif font. The words are stacked on top of each other.
Special 510(k) Premarket Notification Modification to Vital Signs Monitor
K053027 page 3 of 3
| Technological
Characteristics: | The modified Model 53000 Series (VSM 300) vital signs monitor
(i.e., the subject device) has the same technological characteristics
as originally cleared with the predicate device.
It has the same basic design; It uses the same energy source; It uses the same operating principle; It incorporates the same basic materials; and It is packaged using the same materials and processes. Based on these similarities, Welch Allyn believes that the subject
device is substantially equivalent to the VSM Model 53000 Series
that was cleared for marketing under K031740. |
|-----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Performance Data: | The subject device has been tested in accordance with Welch Allyn
documents 831-1031-02, "PE Test Report, VSM 300 Update" and
831-1050-00, "Test Report, VSM 3 Masimo" using production
equivalent units prior to market release.
A risk analysis identifying potential hazards and documenting
mitigation of the hazards has been developed and applied as part of
Welch Allyn Protocol's product development procedure. Welch
Allyn Protocol's Quality System conforms to 21 CFR 820 and is
certified to ISO 9001 and ISO 13485. |
| Conclusions: | Based on the information contained herein, we conclude that the
changes are minor and that the subject device is substantially
equivalent to the predicate device. The intended use of the Vital
Signs Monitor, Model 53000 Series, as described in its labeling, has
not changed as a result of this modification. |
・
.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three bars above it, representing the department's mission to promote health and well-being. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV 2 2 2005
Welch Allyn Protocol, Inc. c/o Mr John E. Sawyer VP, World Wide Regulatory Affairs 8500 S. W. Creekside Place Beaverton, OR 97008-7107
Re: K053027
Trade Name: VSM, Vital Signs Monitor, Model 53000 Series (VSM 300) Regulation Number: 21 CFR 870.2300 Regulation Name: Cardiac Monitor (including cardiotachometer and rate alarm) Regulatory Class: Class II (two) Product Code: MWI Dated: October 14, 2005 Received: October 27, 2005
Dear Mr. Sawyer:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Mr John E. Sawyer
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Bhimmar for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Welch Allyn
Special 510(k) Premarket Notification Modification to Vital Signs Monitor
Statement of Indications for Use র্ব
Applicant:
Welch Allyn Protocol. Inc. 8500 S.W. Creekside Place Beaverton, OR 97008-7107 USA
510(k) Number:
Device Name: VSM, Vital Signs Monitor, Model 53000 Series (VSM 300)
Indications for Use:
The VSM series of monitors is intended to be used by clinicians and medically qualified personnel for monitoring of noninvasive blood pressure, pulse rate, body temperature, noninvasive functional oxygen saturation of arteriolar hemoglobin (SpO2), and body temperature in normal and axillary modes of neonatal, pediatric and adult patients.
The most likely locations for patients to be monitored are general medical and surgical floors, general hospital and alternate care environments. This device is available for sale only upon the order of a physician or licensed health care professional.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (Part 21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Bhummana
Section 4 - Page 1 of 1